Eduardo Vilar Gomez

Summary

Affiliation: Ciudad de La Habana
Country: Cuba

Publications

  1. doi request reprint The natural history of compensated HCV-related cirrhosis: a prospective long-term study
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    J Hepatol 58:434-44. 2013
  2. ncbi request reprint Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Liver Int 27:247-59. 2007
  3. pmc Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease
    Eduardo Vilar Gomez
    National Institute of Gastroenterology, Vedado, Havana, Cuba
    World J Gastroenterol 15:2768-77. 2009
  4. doi request reprint Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
    E Vilar Gomez
    Departments of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Aliment Pharmacol Ther 30:999-1009. 2009
  5. pmc Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, 25th Avenue, 503, Vedado, Havana 10400, Cuba
    World J Gastroenterol 16:2638-47. 2010

Collaborators

  • Eduardo Vilar Gomez
  • Luis Calzadilla Bertot
  • Enrique Arus Soler
  • Ali Yasells Garcia
  • Yadina Martinez Perez
  • Maria del Rosario Abreu Vazquez
  • Luis Perez Blanco
  • Ana Torres Gonzalez
  • Yoan Sanchez Rodriguez
  • Licet Gonzalez Fabian
  • Hector Vega Sanchez
  • Gretel Riveron Forment
  • Javier Diaz Elias
  • Raimundo Llanio Navarro
  • Oscar Villa JimĂ©nez
  • Bienvenido Gra Oramas

Detail Information

Publications5

  1. doi request reprint The natural history of compensated HCV-related cirrhosis: a prospective long-term study
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    J Hepatol 58:434-44. 2013
    ..The natural history of HCV-related compensated cirrhosis has been poorly investigated in Latin-American countries. Our study evaluated mortality and clinical outcomes in compensated cirrhotic patients followed for 6 years...
  2. ncbi request reprint Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Liver Int 27:247-59. 2007
    ..Previous trials suggested that antioxidative therapy may have a beneficial effect. We evaluated the efficacy and safety of Viusid in combination with interferon alpha-2b (IFN alpha-2b) and ribavirin in patients with CHC...
  3. pmc Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease
    Eduardo Vilar Gomez
    National Institute of Gastroenterology, Vedado, Havana, Cuba
    World J Gastroenterol 15:2768-77. 2009
    ..To investigate the capability of a biochemical and clinical model, BioCliM, in predicting the survival of cirrhotic patients...
  4. doi request reprint Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
    E Vilar Gomez
    Departments of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Aliment Pharmacol Ther 30:999-1009. 2009
    ..The combination of weight loss and antioxidant drugs to ameliorate insulin resistance and improve steatosis, inflammation and fibrosis provides the rational for therapeutic trials...
  5. pmc Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, 25th Avenue, 503, Vedado, Havana 10400, Cuba
    World J Gastroenterol 16:2638-47. 2010
    ..To investigate the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C...